Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.73 |
| ▸ | MAPT | P10636 | 2/20 | 0.73 |
| ▸ | RAB9A | P51151 | 2/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | MMP13 | P45452 | 2/20 | 0.58 |
| ▸ | MAOB | P27338 | 1/20 | 0.57 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | STAT3 | P40763 | 1/20 | 0.53 |
| ▸ | STAT1 | P42224 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | ESRRA | P11474 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | ELANE | P08246 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | STS | P08842 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16995927 | 1.00 | HPGD (0.73) | HPGDMAPTRAB9AALDH1A1LMNA | |
| SCHEMBL10014129 | 1.00 | HPGD (0.73) | HPGDMAPTRAB9AALDH1A1LMNA | |
| SCHEMBL9999837 | 1.00 | HPGD (0.73) | HPGDMAPTRAB9AALDH1A1LMNA | |
| SCHEMBL10014131 | 1.00 | HPGD (0.73) | HPGDMAPTRAB9AALDH1A1LMNA | |
| SCHEMBL9999839 | 1.00 | HPGD (0.73) | HPGDMAPTRAB9AALDH1A1LMNA | |
| SCHEMBL12062003 | 1.00 | HPGD (0.73) | HPGDMAPTRAB9AALDH1A1LMNA | |
| SCHEMBL10014135 | 0.95 | MAPT (0.66) | HPGDMAPTRAB9AALDH1A1LMNA | |
| SCHEMBL10014121 | 0.95 | MAPT (0.66) | HPGDMAPTRAB9AALDH1A1LMNA | |
| SCHEMBL10014124 | 0.95 | MAPT (0.66) | HPGDMAPTRAB9AALDH1A1LMNA | |
| SCHEMBL10014126 | 0.95 | MAPT (0.66) | HPGDMAPTRAB9AALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230374237-A1 | METHOD FOR IMPREGNATING REINFORCING FIBRES WITH POLYARYLETHERKETONES AND SEMI-PRODUCTS OBTAINED THEREFROM | ARKEMA FRANCE (FR) | 2023-11-23 | — | — | US | disclosed |
| US-11746188-B2 | Poly(aryl-ether-ketone) (PAEK) powder suitable for multiple use in sintering methods | ARKEMA FRANCE (FR) | 2023-09-05 | — | — | US | disclosed |
| US-11697718-B2 | Method for impregnating reinforcing fibres with polyaryletherketones and semi-products obtained therefrom | ARKEMA FRANCE (FR) | 2023-07-11 | — | — | US | disclosed |
| EP-3347407-B1 | TOUGHENED POLY(ARYL ETHER SULFONE)/POLY(ARYL ETHER KETONE) BLENDS | SOLVAY SPECIALTY POLYMERS USA (US) | 2022-05-04 | — | — | EP | disclosed |
| US-10683415-B2 | PAEK/PPSU/PES compositions | SOLVAY SPECIALTY POLYMERS USA, LLC (US) | 2020-06-16 | — | — | US | disclosed |
| EP-3237493-B1 | PAEK/PPSU/PES COMPOSITIONS | SOLVAY SPECIALTY POLYMERS USA (US) | 2020-04-29 | — | — | EP | disclosed |
| US-10023692-B2 | Method for the manufacture of poly(aryl ether ketone)s in the presence of sodium carbonate | SOLVAY ADVANCED POLYMERS, L.L.C. (US) | 2018-07-17 | — | — | US | disclosed |
| US-20180002524-A1 | PAEK/PPSU/PES Compositions | SOLVAY SPECIALTY POLYMERS USA, LLC (US) | 2018-01-04 | — | — | US | disclosed |
| US-9815937-B2 | Process for preparing a poly(aryl ether ketone) using a high purity 4,4′-difluorobenzophenone | SOLVAY ADVANCED POLYMERS, L.L.C. (US) | 2017-11-14 | — | — | US | disclosed |
| US-9815937-B2 | Process for preparing a poly(aryl ether ketone) using a high purity 4,4′-difluorobenzophenone | SOLVAY ADVANCED POLYMERS, L.L.C. (US) | 2017-11-14 | — | — | US | disclosed |
| US-20090048379-A1 | Polymer Composition | SOLVAY ADVANCED POLYMERS, L.L.C. (US) | 2009-02-19 | — | — | US | disclosed |
| US-20090036594-A1 | Reinforced Blend | SOLVAY ADVANCED POLYMERS, L.L.C. (US) | 2009-02-05 | — | — | US | disclosed |
| US-20090036594-A1 | Reinforced Blend | SOLVAY ADVANCED POLYMERS, L.L.C. (US) | 2009-02-05 | — | — | US | disclosed |
| US-20080312387-A1 | New Polyarylene Composition | SOLVAY ADVANCED POLYMERS, L.L.C. (US) | 2008-12-18 | — | — | US | disclosed |
| US-20080312387-A1 | New Polyarylene Composition | SOLVAY ADVANCED POLYMERS, L.L.C. (US) | 2008-12-18 | — | — | US | disclosed |
| US-20080275193-A1 | Use of Poly(Biphenyl Ether Sulfone)S | SOLVAY ADVANCE POLYMERS, L.L.C. (US) | 2008-11-06 | — | — | US | disclosed |
| US-20080275193-A1 | Use of Poly(Biphenyl Ether Sulfone)S | SOLVAY ADVANCE POLYMERS, L.L.C. (US) | 2008-11-06 | — | — | US | disclosed |
| US-20080254313-A1 | CIRCUIT MATERIALS, MULTILAYER CIRCUITS, AND METHODS OF MANUFACTURE THEREOF | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2008-10-16 | — | — | US | disclosed |
| US-20070265415-A1 | PROCESS FOR PREPARING POLYARYLENE ETHER KETONE | DEGUSSA GMBH (DE) | 2007-11-15 | — | — | US | disclosed |
| US-20070265414-A1 | PROCESS FOR PREPARING POLYARYLENE ETHER KETONES | DEGUSSA AG (DE) | 2007-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10023692-B2 | Method for the manufacture of poly(aryl ether ketone)s in the presence of sodium carbonate | PKM, KCNK10, KCNK9 | HPGD 4652/4885MAPT 3336/4885RAB9A 1581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.